Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04071119Phase 1Completed
Phase 1, randomised, double-blind trial in alcohol use disorder (AUD) and nicotine dependence comparing Oxytocin nasal spray with Placebo (2 arms). Primary endpoints: Alcohol craving at 1 day, Cigarette craving at 1 day and 1 more. Started Nov 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04071119.